Voriconazole-induced central nervous system toxicity: a pharmacovigilance study based on FDA adverse event reporting system (FAERS) database
VRC was significantly associated with the CNS toxicity. Dosing adjustment, model-based individualized treatment project, and the therapeutic drug monitoring-guided individualized medication regime could be good strategies for efficacy improvement and the adverse events of reducing of VRC.
Authors
- Juping Yun (ORCID: https://orcid.org/0009-0007-9087-7031)
- Wei Liu (ORCID: https://orcid.org/0000-0002-3428-9258)
- Zihe Wang (ORCID: https://orcid.org/0009-0007-6518-7119)
Institutions
- Capital Medical University (CN)
- Beijing YouAn Hospital (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1080/14740338.2024.2391492
- Citations
- 6
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 2.33